Reviva Pharmaceuticals Holdings, Inc. Stock
Equities
RVPH
US76152G1004
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -3.57% | +0.75% | -73.79% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 40.25M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -45M | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.8M | Net cash position 2025 * | 1.2M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.22
x | P/E ratio 2025 * |
-1.53
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.42% |
1 day | -3.57% | ||
1 week | +0.75% | ||
Current month | -1.46% | ||
1 month | -57.81% | ||
3 months | -64.38% | ||
6 months | -64.75% | ||
Current year | -73.79% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 20-12-10 | |
Narayan Prabhu
DFI | Director of Finance/CFO | 53 | 20-12-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 69 | 20-12-13 | |
Les Funtleyder
BRD | Director/Board Member | 54 | 20-12-13 |
Founder | 59 | 20-12-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 1.35 | -3.57% | 377,325 |
24-06-04 | 1.4 | -6.67% | 127,083 |
24-06-03 | 1.5 | +9.49% | 267,844 |
24-05-31 | 1.37 | 0.00% | 91,689 |
24-05-30 | 1.37 | +2.24% | 171,084 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.79% | 41.74M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- RVPH Stock